BioLife Solutions Inc (BLFS)
Cash conversion cycle
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 201.49 | 157.90 | 124.60 | 153.69 | 92.90 | 109.82 | 112.73 | 78.10 | 67.28 | 84.42 | 84.75 | 165.84 | 183.80 | 337.61 | 364.65 | 182.66 | 171.30 | 103.50 | 116.87 | 135.39 |
Days of sales outstanding (DSO) | days | 32.53 | 53.18 | 52.44 | 49.52 | 47.69 | 58.20 | 60.73 | 68.18 | 76.92 | 76.64 | 77.34 | 64.11 | 71.31 | 76.46 | 103.96 | 73.79 | 60.77 | 53.93 | 43.30 | 89.16 |
Number of days of payables | days | 24.81 | 18.83 | 16.15 | 17.64 | 7.76 | 30.35 | 30.75 | 29.34 | 29.62 | 32.87 | 29.33 | 64.31 | 96.91 | 162.53 | 138.82 | 66.95 | 54.22 | 22.08 | 33.02 | 44.04 |
Cash conversion cycle | days | 209.21 | 192.25 | 160.89 | 185.56 | 132.83 | 137.67 | 142.72 | 116.94 | 114.58 | 128.20 | 132.76 | 165.63 | 158.20 | 251.54 | 329.79 | 189.50 | 177.85 | 135.35 | 127.15 | 180.52 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 201.49 + 32.53 – 24.81
= 209.21
The cash conversion cycle of BioLife Solutions Inc has shown fluctuations over the periods analyzed. The company's cash conversion cycle measures the time it takes for BioLife Solutions to convert its investments in inventory and other resources into cash flows from sales to ultimately cash receipts.
The trend in the cash conversion cycle shows a decrease from a high of 329.79 days as of June 30, 2021, to a low of 114.58 days as of December 31, 2022, indicating an improvement in the efficiency of cash management. However, the cycle increased slightly to 185.56 days as of March 31, 2024, compared to the low in 2022.
Analyzing the cycles, it appears that BioLife Solutions Inc has been managing its working capital and operations more effectively by reducing the time it takes to convert inventory and accounts receivable into cash, although there have been some fluctuations. Overall, a decreasing trend in the cash conversion cycle is typically considered positive as it indicates the company is collecting cash from sales more quickly and efficiently.
Peer comparison
Dec 31, 2024